MiRNA-based therapy for Human Cancer: MiRNA-217 suppresses the expression of Tripeptidyl Peptidase 1 (TPP1) via up regulation of its target gene, 1/July/2014, 10.25 am

Anti-miRNA based therapy for NIDDM: Increased expression of Stress-responsive miRNA-195 promotes gluconeogenesis and hyperglycemia via down regulation of Cyclin D1, 1/July/2014, 10.18 am
July 1, 2014
Comination therapy for Hepatocellular carcinoma: miRNA-375 and American Ginseng inhibit Hepatocarcionogenesis progression via down regulation of their target genes, 2/July/2014, 5.17 am
July 1, 2014
Show all

The 1989 Noble prize winner in ChemistryProf. Thomas R. Cech from the University of Colorado BioFrontiers Institute, USA has published a research paper in the 13 December 2012 Nature (492(7428):285-9; I.F: >35) stating that “The TEL patch of telomere protein TPP1 mediates telomerase recruitment and processivity.”  This study provides mechanistic insights into how TPP1 regulates telomerase function.

In connection with this finding, Dr Boominathan, Founder Director-cum-chief scientist of GBMD, reports that: MiRNA-based therapy for Human Cancer:  MiRNA-217 suppresses the expression of Tripeptidyl Peptidase 1 (TPP1) via up regulation of its target gene Remarkably, over 90% human tumors over express telomerase, suggesting that inhibition of its activity may increase the efficacy of anticancer therapy.  Together, this study suggests that pharmacological formulations containing “miRNA-217 activators” can be used in the treatment of human cancers.

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan,   MiRNA-based therapy for Human Cancer:  MiRNA-217 suppresses the expression of Tripeptidyl Peptidase 1 (TPP1) via up regulation of its target gene, 1/July/2014, 10.26 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Comments are closed.